Drug Development

Listings
  • Anti-CXCR4 (ulocuplumab)-pAcF-MMAF ADC

    Anti-CXCR4 (ulocuplumab)-pAcF-MMAF ADC

    Drug Development Shirley (New York) November 29, 2017 1.00 Dollar US$

    This ADC product is comprised of an anti-CXCR4 monoclonal antibody (ulocuplumab) conjugated via a pAcF linker to a MMAF. The MMAF is targeted to certain cancers by immunerecognition and delivered into cancer cells via receptor mediated endocytosis. W...

  • Anti-CD79b (clone hu2F2.D7)-SMCC-DM1 ADC

    Anti-CD79b (clone hu2F2.D7)-SMCC-DM1 ADC

    Drug Development Shirley (New York) November 10, 2017 1.00 Dollar US$

    This ADC product is comprised of an anti-CD79B monoclonal antibody (clone hu2F2.D7) conjugated via a SMCC linker to DM1. The DM1 is targeted to certain cancers by immunerecognition and delivered into cancer cells via receptor mediated endocytosis. Wi...

  • Anti-CXCR4-PEG-S-4FB-dasatinib ADC

    Anti-CXCR4-PEG-S-4FB-dasatinib ADC

    Drug Development Shirley (New York) November 29, 2017 1.00 Dollar US$

    This ADC product is comprised of an anti-CXCR4 monoclonal antibody conjugated via a PEG-S-4FB linker to dasatinib. Dasatinib, also known as BMS-354825, is a cancer drug. It is an oral Bcr-Abl tyrosine kinase inhibitorand Src family tyrosine kinase in...

  • Anti-CD79b (clone hu2F2.D7)-BMPEO-DM1 ADC

    Anti-CD79b (clone hu2F2.D7)-BMPEO-DM1 ADC

    Drug Development Shirley (New York) November 10, 2017 1.00 Dollar US$

    This ADC product is comprised of an anti-CD79B monoclonal antibody (clone hu2F2.D7) conjugated via a BMPEO linker to DM1. The DM1 is targeted to certain cancers by immunerecognition and delivered into cancer cells via receptor mediated endocytosis. W...

  • Anti-DLL3 (clone SC16.15)-PBD dimers ADC

    Anti-DLL3 (clone SC16.15)-PBD dimers ADC

    Drug Development Shirley (New York) November 29, 2017 1.00 Dollar US$

    This ADC product is comprised of an anti-DLL3 monoclonal antibody (clone SC16.15) conjugated via a linker to PBD dimers. The PBD dimers is targeted to certain cancers by immunerecognition and delivered into cancer cells via receptor mediated endocyto...

  • Anti-CD79b (clone hu2F2.D7)-Mc-MMAF ADC

    Anti-CD79b (clone hu2F2.D7)-Mc-MMAF ADC

    Drug Development Shirley (New York) November 10, 2017 1.00 Dollar US$

    This ADC product is comprised of an anti-CD79B monoclonal antibody (clone hu2F2.D7) conjugated via a Mc linker to MMAF. The MMAF is targeted to certain cancers by immunerecognition and delivered into cancer cells via receptor mediated endocytosis. Wi...

  • Anti-CXCR4-dasatinib ADC

    Anti-CXCR4-dasatinib ADC

    Drug Development Shirley (New York) November 29, 2017 1.00 Dollar US$

    This ADC product is comprised of an anti-CXCR4 monoclonal antibody conjugated via a linker to dasatinib. Dasatinib, also known as BMS-354825, is a cancer drug. It is an oral Bcr-Abl tyrosine kinase inhibitorand Src family tyrosine kinase inhibitor ap...

  • Anti-CD79b (clone hu2F2.D7)-Mc-vc-PABC-MMAE ADC

    Anti-CD79b (clone hu2F2.D7)-Mc-vc-PABC-MMAE ADC

    Drug Development Shirley (New York) November 10, 2017 1.00 Dollar US$

    This ADC product is comprised of an anti-CD79B monoclonal antibody (clone hu2F2.D7) conjugated via a Mc-vc-PABC linker to MMAE. The MMAE is targeted to certain cancers by immunerecognition and delivered into cancer cells via receptor mediated endocyt...

  • Anti-DLL3 (clone SC16.46)-PBD dimers ADC

    Anti-DLL3 (clone SC16.46)-PBD dimers ADC

    Drug Development Shirley (New York) November 29, 2017 1.00 Dollar US$

    This ADC product is comprised of an anti-DLL3 monoclonal antibody (clone SC16.46) conjugated via a linker to PBD dimers. The PBD dimers is targeted to certain cancers by immunerecognition and delivered into cancer cells via receptor mediated endocyto...

  • Anti-CD79b (clone ch2F2)-Mc-MMAF ADC

    Anti-CD79b (clone ch2F2)-Mc-MMAF ADC

    Drug Development Shirley (New York) November 10, 2017 1.00 Dollar US$

    This ADC product is comprised of an anti-CD79B monoclonal antibody (clone ch2F2) conjugated via a Mc linker to MMAF. The MMAF is targeted to certain cancers by immunerecognition and delivered into cancer cells via receptor mediated endocytosis. Withi...

  • Anti-DLL3 (clone SC16.13)-PBD dimers ADC

    Anti-DLL3 (clone SC16.13)-PBD dimers ADC

    Drug Development Shirley (New York) November 29, 2017 1.00 Dollar US$

    This ADC product is comprised of an anti-DLL3 monoclonal antibody (clone SC16.13) conjugated via a linker to PBD dimers. The PBD dimers is targeted to certain cancers by immunerecognition and delivered into cancer cells via receptor mediated endocyto...

  • Anti-CD79b (clone ch2F2)-Mc-MMAF ADC

    Anti-CD79b (clone ch2F2)-Mc-MMAF ADC

    Drug Development Shirley (New York) November 11, 2017 1.00 Dollar US$

    This ADC product is comprised of an anti-CD79B monoclonal antibody (clone ch2F2) conjugated via a Mc linker to MMAF. The MMAF is targeted to certain cancers by immunerecognition and delivered into cancer cells via receptor mediated endocytosis. Withi...